Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

John Kelly

Dermatology East Greenwich, RI Medical Doctor

NPI 1043599269 CMS profile 1286935

1672 S County Trl, East Greenwich, RI 02818

Open in the dashboard

General payments

$96,948

148 records reported · program years 2019–2022

Research payments

$2,528

Paid to them · 2 records reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$377,952 paid to institutions, not to them · program years 2019–2022

Through program year 2022, John Kelly of East Greenwich, RI is reported in the CMS Open Payments database as having received $96,948 across 148 general payments and $2,528 in research payments paid to them. Separately, studies naming them as principal investigator received $377,952 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $4,661 12
2021 General $20,626 32
2021 Research $153 1
2020 General $23,002 26
2020 Research $2,375 1
2019 General $48,659 78

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Kelly
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to John Kelly were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year John Kelly Dermatology median Middle half National median
2019 $48,659 $454 $129–$1,240 $163
2020 $23,002 $235 $81–$756 $114
2021 $20,626 $377 $108–$1,108 $132
2022 $4,661 $514 $143–$1,391 $149
2023 $0 $607 $159–$1,674 $160
2024 $0 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. AbbVie, Inc. $92,841 105 payments
  2. Novartis Pharmaceuticals Corporation $2,914 11 payments
  3. EPI Health, LLC $271 2 payments
  4. Lilly USA, LLC $169 6 payments
  5. Sanofi-Aventis U.S. LLC $114 4 payments
  6. Janssen Biotech, Inc. $111 4 payments
  7. Sun Pharmaceutical Industries Inc. $100 1 payment
  8. Pfizer Inc. $99 6 payments
  9. Celgene Corporation $91 1 payment
  10. Amgen Inc. $87 1 payment
  11. Other $151 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $81,692 33 payments
  2. Travel and Lodging $8,523 25 payments
  3. Food and Beverage $4,372 86 payments
  4. Consulting Fee $2,250 1 payment
  5. Education $112 3 payments
Products named General payments · program years 2019–2022
  1. SKYRIZI $44,869 51 payments
  2. HUMIRA $37,497 43 payments
  3. COSENTYX Immunology $2,776 7 payments
  4. RINVOQ $1,982 8 payments
  5. COSENTYX Dermatology $329 5 payments
  6. WYNZORA $271 2 payments
  7. RHOFADE $160 1 payment
  8. MINOLIRA EXTENDED RELEASE Dermatology $160 1 payment
  9. MINOLIRA EXTENDED RELEASE Dermatology $160 1 payment
  10. CLODERM $160 1 payment
  11. Other $784 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2022
  1. AbbVie, Inc. $2,375 1 payment
  2. Eli Lilly and Company $153 1 payment

Records

150 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Rhode Island

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record